JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB98593

Goat F(ab')2 Anti-Human IgG - Fc (DyLight® 650), pre-adsorbed

Be the first to review this product! Submit a review

|

(5 Publications)

Suitable for Flow Cyt, ICC/IF, IHC-P. Preadsorbed to minimise non-specific binding and high background staining. Cited in 5 publications.

View Alternative Names

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1

Key facts

Host species

Goat

Target species

Human

Target isotype

IgG

Target specificity

Fc region

Minimal cross-reactivity

Mouse, Rat,

Pre-adsorbed

Yes

Conjugation

DyLight® 650

Excitation/Emission

Ex: 654nm, Em: 673nm

Applications

ICC/IF, IHC-P, Flow Cyt

applications

Clonality

Polyclonal

Isotype

IgG

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Flow Cyt": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/50 - 1/200", "notes":"<p></p>" }, "ICC/IF": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/50 - 1/500", "notes":"<p></p>" }, "IHC-P": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/50 - 1/500", "notes":"<p>DyLight<sup>®</sup> 650 replaces DyLight<sup>®</sup> 649. The DyLight<sup>®</sup> 650 excitation is 652nm and the emission is 672nm. DyLight<sup>®</sup> 650 hence provides the same far-red fluorescence and photostability as the DyLight<sup>®</sup> 649 dye. Please refer to the vial in order to check whether the product you received is DyLight<sup>®</sup> 649 or DyLight<sup>®</sup> 650. This information however will have no impact on your experiments.</p>" } } }

Product details

DyLight® 650 replaces DyLight® 649.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
This antibody was isolated by affinity chromatography using antigen coupled to agarose beads. F(ab')2 fragment were generated using a pepsin digestion. Fc fragments and whole IgG molecules have been removed. Fragments were conjugated to DyLight® 650.
Storage buffer
pH: 6.8 - 7.4 Preservative: 0.09% Sodium azide Constituents: PBS, 0.2% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Product protocols

Target data

Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed : 20176268, PubMed : 22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed : 17576170, PubMed : 20176268). Mediates IgG effector functions on monocytes triggering ADCC of virus-infected cells.
See full target information IGHG1

Additional targets

IGHG3,IGHG4,IGHG2

Publications (5)

Recent publications for all applications. Explore the full list and refine your search

Theranostics 14:6249-6267 PubMed39431011

2024

Development of a CD39 nanobody and its enhancement to chimeric antigen receptor T cells efficacy against ovarian cancer in preclinical studies.

Applications

Unspecified application

Species

Unspecified reactive species

Yu-Chen Zhang,Xian-Yang Li,Qi Deng,Yan-Jun Ge,Rui-Rong Yi,Hua-Jing Wang,Jian-Tao Wang,Hui Zhou,Xue-Feng Kong,Rong-Jiao Liu,Yu-Ting Zhang,Xiao-Pei Li,Xiao-Wen He,Hai-Yan Zhu

Immunity 57:2140-2156.e10 PubMed39226900

2024

Antibodies and complement are key drivers of thrombosis.

Applications

Unspecified application

Species

Unspecified reactive species

Konstantin Stark,Badr Kilani,Sven Stockhausen,Johanna Busse,Irene Schubert,Thuy-Duong Tran,Florian Gaertner,Alexander Leunig,Kami Pekayvaz,Leo Nicolai,Valeria Fumagalli,Julia Stermann,Felix Stephan,Christian David,Martin B Müller,Birgitta Heyman,Anja Lux,Alexandra da Palma Guerreiro,Lukas P Frenzel,Christoph Q Schmidt,Arthur Dopler,Markus Moser,Sue Chandraratne,Marie-Luise von Brühl,Michael Lorenz,Thomas Korff,Martina Rudelius,Oliver Popp,Marieluise Kirchner,Philipp Mertins,Falk Nimmerjahn,Matteo Iannacone,Markus Sperandio,Bernd Engelmann,Admar Verschoor,Steffen Massberg

Scientific reports 12:18011 PubMed36289396

2022

Development of a bispecific antibody targeting PD-L1 and TIGIT with optimal cytotoxicity.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenwei Zhong,Mengyao Zhang,Yanan Ning,Guanchao Mao,Xiaopei Li,Qi Deng,Xiaorui Chen,Dongliang Zuo,Xiangyu Zhao,Ermin Xie,Huajing Wang,Lina Guo,Bohua Li,Kai Xiao,Xiaowen He

Medical oncology (Northwood, London, England) 39:205 PubMed36175701

2022

Targeting acute myeloid cell surface using a recombinant antibody isolated from whole-cell biopanning of a phage display human scFv antibody library.

Applications

Unspecified application

Species

Unspecified reactive species

Thitima Sumphanapai,Kerry Chester,Surasak Sawatnatee,Jenny Yeung,Montarop Yamabhai

European journal of immunology 44:3585-95 PubMed25229656

2014

Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Inge Langers,Virginie Renoux,Anca Reschner,Antoine Touzé,Pierre Coursaget,Jacques Boniver,Joachim Koch,Philippe Delvenne,Nathalie Jacobs
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com